Drug-related hospital admissions

OBJECTIVE: To review and summarize studies reporting rates of drug-related hospital admissions. DATA SOURCES: Manual and computerized literature searches using MEDLINE, Index Medicus, and International Pharmaceutical Abstracts as databases (key words: drug, drug-related, or iatrogenic; admission, hospital admission, or hospitalization; and ADR or adverse drug reaction). References from retrieved articles were searched to locate further studies. STUDY SELECTION: Included were English-language studies of humans admitted to the hospital because of medications. Problems investigated were admissions prompted by adverse drug reactions (ADRs) when drugs were used by the patient and admissions resulting from a patient's noncompliant or unintentionally inappropriate drug use. Excluded were cases involving drug abuse, alcoholism, suicide attempts, intoxication, or inadequate prescribing. DATA SYNTHESIS: Between 1966 and 1989, ADR rates from 49 hospitals or groups of hospitals in a variety of international settings were published in 36 articles. Samples sizes ranged from 41 to 11,891 patients, with a median of 714 (interquartile range [IQR] 275-1245) and a mean of 1412 (SD 2233). The prevalence of reported admissions resulting from ADRs ranged from 0.2 to 21.7 percent; the median was 4.9 percent (IQR 2.9-6.7 percent) and the mean was 5.5 percent (SD 4.1 percent). The weighted meta-analytic estimate was 5.1 percent (95 percent confidence interval 4.4-5.8). Of those ADR admissions, 71.5 percent were side effects, 16.8 percent excessive effects, 11.3 percent hypersensitivity reactions, and 0.4 percent idiosyncratic; 3.7 percent of patients admitted for ADRs died. Eleven reports indicated that 22.7 percent of ADR hospitalizations were induced by noncompliance. CONCLUSIONS: Drug-induced hospitalizations account for approximately five percent of all admissions. Results apply only to people from highly developed industrialized countries. Economic analyses have not been performed. Future research should include the Third World and nonindustrialized nations as well as specific cultural groups.

This article has been cited by other articles:

				L. Dolovich, K. Nair, C. Sellors, L. Lohfeld, A. Lee, and M. Levine Do patients' expectations influence their use of medications?: Qualitative study Can Fam Physician, March 1, 2008; 54(3): 384 - 393. [Abstract] [Full Text] [PDF]

				L. A. Thomsen, A. G Winterstein, B. Sondergaard, L. S. Haugbolle, and A. Melander Systematic Review of the Incidence and Characteristics of Preventable Adverse Drug Events in Ambulatory Care Ann. Pharmacother., September 1, 2007; 41(9): 1411 - 1426. [Abstract] [Full Text] [PDF]

				M. G. Katz, S. Kripalani, and B. D. Weiss Use of pictorial aids in medication instructions: A review of the literature Am. J. Health Syst. Pharm., December 1, 2006; 63(23): 2391 - 2397. [Abstract] [Full Text] [PDF]

				D.A. Gorard Escalating polypharmacy QJM, November 1, 2006; 99(11): 797 - 800. [Abstract] [Full Text] [PDF]

				N. N. Bumpus, U. M. Kent, and P. F. Hollenberg Metabolism of Efavirenz and 8-Hydroxyefavirenz by P450 2B6 Leads to Inactivation by Two Distinct Mechanisms J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 345 - 351. [Abstract] [Full Text] [PDF]

				W. E Fassett Patient Safety and Quality Improvement Act of 2005 Ann. Pharmacother., May 1, 2006; 40(5): 917 - 924. [Abstract] [Full Text] [PDF]

				P. J. Trapskin, L. White, and J. A. Armitstead Improving the accuracy of patient identification in the medication-use process Am. J. Health Syst. Pharm., February 1, 2006; 63(3): 218 - 222. [Full Text] [PDF]

				P. J. Zed Drug-Related Visits to the Emergency Department Journal of Pharmacy Practice, October 1, 2005; 18(5): 329 - 335. [Abstract] [PDF]

				C A. Oborne and M. L Luzac Over-the-Counter Medicine Use Prior to and During Hospitalization Ann. Pharmacother., February 1, 2005; 39(2): 268 - 273. [Abstract] [Full Text] [PDF]

				M. Pirmohamed, S. James, S. Meakin, C. Green, A. K Scott, T. J Walley, K. Farrar, B K. Park, and A. M Breckenridge Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients BMJ, July 3, 2004; 329(7456): 15 - 19. [Abstract] [Full Text] [PDF]

				A. J. McLean and D. G. Le Couteur Aging Biology and Geriatric Clinical Pharmacology Pharmacol. Rev., June 1, 2004; 56(2): 163 - 184. [Abstract] [Full Text] [PDF]

				D. S. Bell, S. Cretin, R. S. Marken, and A. B. Landman A Conceptual Framework for Evaluating Outpatient Electronic Prescribing Systems Based on Their Functional Capabilities J. Am. Med. Inform. Assoc., January 1, 2004; 11(1): 60 - 70. [Abstract] [Full Text] [PDF]

				W. J. Pichler Delayed Drug Hypersensitivity Reactions Ann Intern Med, October 21, 2003; 139(8): 683 - 693. [Abstract] [Full Text] [PDF]

				J. Sellors, J. Kaczorowski, C. Sellors, L. Dolovich, C. Woodward, A. Willan, R. Goeree, R. Cosby, K. Trim, R. Sebaldt, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients Can. Med. Assoc. J., July 8, 2003; 169(1): 17 - 22. [Abstract] [Full Text] [PDF]

				D. N. Juurlink, M. Mamdani, A. Kopp, A. Laupacis, and D. A. Redelmeier Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity JAMA, April 2, 2003; 289(13): 1652 - 1658. [Abstract] [Full Text] [PDF]

				A. J. Barsky, R. Saintfort, M. P. Rogers, and J. F. Borus Nonspecific Medication Side Effects and the Nocebo Phenomenon JAMA, February 6, 2002; 287(5): 622 - 627. [Abstract] [Full Text] [PDF]

				S Malhotra, R S Karan, P Pandhi, and S Jain Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance Postgrad. Med. J., November 1, 2001; 77(913): 703 - 707. [Abstract] [Full Text] [PDF]

				J. Allard, R. Hebert, M. Rioux, J. Asselin, and L. Voyer Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people Can. Med. Assoc. J., May 1, 2001; 164(9): 1291 - 1296. [Abstract] [Full Text] [PDF]

				A. R. Kallianpur, K. A. Poehling, and R. S. Dittus High Time for Action N. Engl. J. Med., January 4, 2001; 344(1): 48 - 51. [Full Text] [PDF]

				S. G. Poole and M. J. Dooley Establishing a baseline incidence of adverse drug reactions in hospitalised oncology patients Journal of Oncology Pharmacy Practice, June 1, 2000; 6(2): 55 - 59. [Abstract] [PDF]

				P. Pouyanne, F. Haramburu, J. L. Imbs, and B. Bégaud Admissions to hospital caused by adverse drug reactions: cross sectional incidence study BMJ, April 15, 2000; 320(7241): 1036 - 1036. [Full Text]

				G. A. Burkhart, D. Shatin, J. S. Gardner, A. Stergachis, J. J. Rybacki, T. J. Moore, B. M. Psaty, and C. D. Furberg Time for Action on Drug Safety JAMA, January 27, 1999; 281(4): 319 - 322. [Full Text] [PDF]

				M. Pirmohamed, A. M Breckenridge, N. R Kitteringham, and B K. Park Fortnightly review: Adverse drug reactions BMJ, April 25, 1998; 316(7140): 1295 - 1298. [Full Text]

				J. Lazarou, B. H. Pomeranz, and P. N. Corey Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies JAMA, April 15, 1998; 279(15): 1200 - 1205. [Abstract] [Full Text] [PDF]

				J. Wyatt and R. Walton Computer based prescribing BMJ, November 4, 1995; 311(7014): 1181 - 1182. [Full Text]